Artemis Medicare Services Q1 FY27: Margins expand as capacity plans accelerate

Artemis Medicare Services opened FY27 with a strong profitability quarter, driven by operating leverage at its flagship Gurugram hospital and continued strength in high acuity specialties. On a consolidated basis, revenue from operations rose to INR 287.32 crore in Q1 FY27, up 12.7% year on year. EBITDA from operations increased to INR 61.82 crore, translating into a 21.5% margin versus 19.0% a year ago. Profit after tax grew 48.3% to INR 31.44 crore, taking the PAT margin to 10.9%.

The performance is notable because the margin expansion outpaced revenue growth. Management attributed this to scale benefits at Gurugram, tighter resource utilization, and a shift toward more complex tertiary and quaternary procedures. The company also used the quarter to frame its next phase of growth, anchored by the newly commissioned Raipur hospital and a large brownfield expansion plan at the Gurugram campus.

Core operating engine: Gurugram continues to deepen its case mix

At the Gurugram facility, Q1 FY27 revenue from operations grew 15.4% year on year to INR 278.49 crore. Bed occupancy improved to 65.7% from 61.2% a year earlier, while ARPOB increased 7.4% year on year to INR 85,690. The company also reported an improvement in operating efficiency with average length of stay reducing to 3.54 days from 3.67.

Financially, the Gurugram hospital delivered EBITDA of INR 61.63 crore with an EBITDA margin of 22.1% in Q1 FY27, up from 20.5% in Q1 FY26. Management repeatedly stressed that the flagship contributes the bulk of revenues and that the primary driver of margin expansion is operating leverage, supported by case mix improvement and cost discipline.

A key insight from the call was management confidence in further margin improvement at the flagship. When asked whether Gurugram margins could move to 23% to 24% over the next two to three years, management responded in the affirmative. Another exchange suggested that at larger scale, margins could be upwards of 23%.

Raipur goes live: early ramp-up phase with clear timelines

A major milestone in the quarter was the commencement of Artemis Shanti Hospital in Raipur, a 300 bed multi-specialty tertiary care hospital. Management outlined a soft launch on 9 July 2026 for OPD services, followed by the start of operating theatres and the cath lab on 27 July 2026. The hospital is positioned to address a gap in advanced healthcare infrastructure in the region, with key specialties including cardiology, oncology, neurosciences, orthopaedics, nephrology, critical care and emergency medicine.

Management shared that most services are being started together rather than in a slow phased build, citing the commencement of advanced procedures soon after launch. They stated total capex of about INR 120 crore, with roughly 80% already spent. PET-CT was described as under installation, and radiotherapy equipment as on the way, with an indicated time of about six months for transportation.

The call also provided a pragmatic ramp-up view. Management guided that the Raipur unit may take around 15 to 18 months to break even and referenced an overall operating loss of about INR 20 crore during the ramp-up. Insurance empanelment was highlighted as a near-term driver, with direct empanelment targeted in 8 to 10 weeks, while interim arrangements are in place to offer a cashless experience.

Capacity and capital allocation: Gurugram Tower IV, South Delhi and funding plans

Artemis framed its growth strategy around multi-year capacity additions, aiming to scale bed capacity to around 2,000 over the next three to five years. The near-term anchor is a proposed Tower IV at the Gurugram campus, guided at 200 plus beds. Management described Tower IV as a consolidation of advanced women and child care and quaternary pediatric services, with the aim of creating a single dedicated tower that can support demand and reduce patient denial as occupancy rises.

The expansion is enabled by a combination of additional FAR obtained through Platinum Green Building certification and incremental FAR purchase to utilize permissible construction. Management guided a timeline of about 18 to 22 months to operationalize, subject to approvals. They also provided capex guidance of about INR 55 lakh per bed including additional parking, and referenced a total cost of about INR 120 crore for the tower with parking.

Beyond Gurugram, the investor presentation highlighted a 650 plus bed South Delhi super-specialty hospital under a 30-year operating agreement, positioned as an asset-light expansion with operating control. The expected operational date is Q4 FY2029.

To fund growth, shareholders have approved a proposed fund raise up to INR 700 crore through QIP. Management clarified that this is an enabling resolution and that timing depends on finalizing assets, mainly brownfield opportunities closer to EBITDA break-even or positive EBITDAs. An indicative timeline of six to eight months was mentioned. The company also guided a capex plan of about INR 800 crore over the next three years, which includes Raipur, Tower IV, VIMHANS and replacement capex. Separately, deposits for VIMHANS were stated as over and above this capex, around INR 250 crore, with about INR 130 crore already paid.

Takeaways

Q1 FY27 reinforced Artemis Medicare Services core thesis of premium realisations and operating leverage at its flagship. Consolidated margins expanded materially while revenue growth stayed healthy. The next phase is execution heavy, with Raipur requiring a ramp-up to break-even, Gurugram Tower IV needing approvals and rapid construction, and the South Delhi project remaining longer dated.

What stood out in this quarter was management willingness to quantify timelines and unit economics. The company has clearly articulated expected commissioning timelines, capex per bed for Tower IV, and the break-even horizon for Raipur. Execution and funding discipline will remain key watch points as Artemis moves toward its targeted capacity scale.